#6 - Coursera (NYSE:COUR)
Some love it; others hate it, but online learning is here to stay, and Coursera Inc. (NYSE: COUR) is one of the leading names in the space. Like 10x Genomics, this small company is not yet profitable. Although the company continues to grow its top line year over year, the growth is showing signs of slowing.
That's likely to be a temporary headwind. The company is focusing on the higher learning market as well as professional certifications. These areas will continue to see strength, especially with individuals looking for remote education opportunities. The company is also leaning into the need for workers in low-skill jobs who need to increase their digital skills.
That said, COUR stock may simply be a case of a stock that got ahead of itself. The company went public in April 2021. At that time, remote and online learning seemed the new normal. It certainly has a place, but not to juscompany'scompany’s $45.78 debut price. Nevertheless, despite lowering some price targets, analysts still give the stock a 116% upside.
About Coursera
Coursera, Inc operates an online educational content platform in the United States, Europe, Africa, the Asia Pacific, the Middle East, and internationally. It operates in three segments: Consumer, Enterprise, and Degrees. The company offers guided projects, courses, and specializations, as well as online degrees; and certificates for entry-level professional, non-entry level professional, university, and MasterTrack.
Read More - Current Price
- $8.31
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 9 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $10.52 (26.6% Upside)
